Now Enrolling
RESTRAIN-SUI Clinical Research Study · Tustin, CA

Are you living with stress urinary incontinence?

Prestige Medical Group is currently enrolling participants in the RESTRAIN-SUI Study — a clinical research trial sponsored by Eli Lilly and Company. This study is designed for women who experience stress urinary incontinence (SUI) and are overweight or have obesity.

Women 18+
BMI 27+
Eli Lilly sponsored
Dr. Gabal, PI
Understanding the Condition

What is stress urinary incontinence?

Stress urinary incontinence (SUI) is the accidental leakage of urine during everyday activities that place pressure on the bladder. It’s more common than many women realize — and there’s nothing shameful about it.

Coughing
Sneezing
Laughing
Running
Exercising
Lifting
Mixed Urinary Incontinence (MUI): Some women experience both stress incontinence and urge incontinence — a sudden, intense need to urinate that may cause leakage before reaching the toilet. The RESTRAIN-SUI Study may also be appropriate for women with MUI who experience mostly stress symptoms.
About the Study

The RESTRAIN-SUI research trial

RESTRAIN-SUI
Clinical Research Study · Sponsored by Eli Lilly and Company

The RESTRAIN-SUI Clinical Research Study is designed specifically for women (people assigned female at birth) who experience stress urinary incontinence and are overweight or have obesity. By participating, you may be among the first to benefit from new research approaches — and help advance the future of SUI care for women like you.

Could You Take Part?

Eligibility criteria

Below are the primary criteria for participating. Additional eligibility requirements will be reviewed during your initial screening visit.

You May Qualify If

Inclusion Criteria
You are 18 years or older
You were assigned female at birth
You have a BMI of 27 or higher
You have not lost or gained more than 5 kg in the past 3 months
You experience daily urinary leakage (SUI only, or MUI with mostly stress symptoms)

You May Not Qualify If

Exclusion Criteria
You have diabetes
You currently take any anti-obesity medications
You currently take any SUI medications
You currently take any overactive bladder medications
Additional eligibility requirements will be reviewed in detail during your initial screening visit. If you’re unsure whether you qualify, our research team is happy to help you find out.
Principal Investigator

Led by Dr. Lamia Gabal, MD, FPMRS

Dr. Gabal serves as the principal investigator for the RESTRAIN-SUI study at Prestige Medical Group. Board-certified in urology with a subspecialty in Female Pelvic Medicine and Reconstructive Surgery, she brings deep expertise in women’s pelvic health to her oversight of participants — and remains your physician throughout the study and beyond.

Interested in Learning More?

Connect with our
research team

If you think you may qualify — or would simply like more information — our research team is here to answer your questions, no commitment required.

You are under no obligation to participate by inquiring. We look forward to helping you learn more about this opportunity.

Have questions? We have answers.

Reach out to our research team to learn whether you may qualify for the RESTRAIN-SUI study — no pressure, no obligation, just information.